Carolin Mogler

Summary

Affiliation: University of Heidelberg
Country: Germany

Publications

  1. ncbi Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer
    Christoph Kahlert
    Department of General, Visceral and Transplantation Surgery, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany
    BMC Cancer 11:275. 2011
  2. ncbi A primary malignant ependymoma of the abdominal cavity: a case report and review of the literature
    Carolin Mogler
    Department of General Pathology, University Hospital, Heidelberg, Germany
    Virchows Arch 454:475-8. 2009
  3. ncbi Heparanase expression in head and neck squamous cell carcinomas is associated with reduced proliferation and improved survival
    Carolin Mogler
    Institute of Pathology, University of Heidelberg, Heidelberg, Germany
    Histopathology 58:944-52. 2011
  4. ncbi Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis
    Philipp Beckhove
    Tumor Immunology Program, German Cancer Research Center, University of Heidelberg, Heidelberg, Germany
    Clin Cancer Res 11:2899-906. 2005
  5. ncbi Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro
    Christoph Kahlert
    Department of General, Visceral and Transplantation Surgery, Institute of Pathology, University of Heidelberg, and German Cancer Research Center, Division of Biostatistics, Heidelberg, Germany
    Clin Cancer Res 17:7654-63. 2011
  6. ncbi Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy
    Christoph Kahlert
    Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany
    Ann Surg Oncol 19:4193-201. 2012
  7. ncbi Annexin A2 as a differential diagnostic marker of hepatocellular tumors
    Thomas Longerich
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
    Pathol Res Pract 207:8-14. 2011
  8. ncbi Elevated expression of c-kit in small venous malformations of blue rubber bleb nevus syndrome
    Carolin Mogler
    Institute of Pathology, Heidelberg, Germany
    Rare Tumors 2:e36. 2010
  9. ncbi Association of stem cell-related markers and survival in astrocytic gliomas
    Feng Wan
    Division of Neurosurgical Research, Department of Neurosurgery, University of Heidelberg, INF 400, 69120 Heidelberg, Germany
    Biomarkers 16:136-43. 2011

Collaborators

Detail Information

Publications9

  1. ncbi Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer
    Christoph Kahlert
    Department of General, Visceral and Transplantation Surgery, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany
    BMC Cancer 11:275. 2011
    ..Recently, ALDH1A1 has been described as a prognostic marker in a pancreatic cancer tissue microarray. The aim of this study was to reevaluate the expression of ALDH1A1 as a prognostic marker on whole-mount tissue sections...
  2. ncbi A primary malignant ependymoma of the abdominal cavity: a case report and review of the literature
    Carolin Mogler
    Department of General Pathology, University Hospital, Heidelberg, Germany
    Virchows Arch 454:475-8. 2009
    ..In conclusion, primary extraneural ependymomas have to be included into the differential diagnosis of abdominal tumors with pseudorosette-formation, even in unusual sites, and GFAP-immunohistochemistry (IHC) supports the diagnosis...
  3. ncbi Heparanase expression in head and neck squamous cell carcinomas is associated with reduced proliferation and improved survival
    Carolin Mogler
    Institute of Pathology, University of Heidelberg, Heidelberg, Germany
    Histopathology 58:944-52. 2011
    ..The present analysis, has studied the role of heparanase in tumour growth and clinical outcome in patients with head and neck squamous cell carcinoma (HNSCC)...
  4. ncbi Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis
    Philipp Beckhove
    Tumor Immunology Program, German Cancer Research Center, University of Heidelberg, Heidelberg, Germany
    Clin Cancer Res 11:2899-906. 2005
    ..We analyzed the presence of heparanase in HNSCC tissues and tumor cells and its potential prognostic significance...
  5. ncbi Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro
    Christoph Kahlert
    Department of General, Visceral and Transplantation Surgery, Institute of Pathology, University of Heidelberg, and German Cancer Research Center, Division of Biostatistics, Heidelberg, Germany
    Clin Cancer Res 17:7654-63. 2011
    ..The aim of this study was to explore the expression of EMT-associated genes at the invasive front in colorectal cancer and to evaluate their prognostic significance...
  6. ncbi Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy
    Christoph Kahlert
    Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany
    Ann Surg Oncol 19:4193-201. 2012
    ..We have investigated the prognostic role of ALDH1A1 in primary colorectal cancer and its value in predicting response to chemotherapy in metastatic colorectal cancer...
  7. ncbi Annexin A2 as a differential diagnostic marker of hepatocellular tumors
    Thomas Longerich
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
    Pathol Res Pract 207:8-14. 2011
    ..In conclusion, we suggest that adding ANXA2 to the established diagnostic marker panel increases the reliability and objectivity of HCC diagnosis in liver biopsies...
  8. ncbi Elevated expression of c-kit in small venous malformations of blue rubber bleb nevus syndrome
    Carolin Mogler
    Institute of Pathology, Heidelberg, Germany
    Rare Tumors 2:e36. 2010
    ..We therefore conclude that pharmacological inhibition of the c-kit signaling pathway in cavernous hemangiomas by selective kinase inhibitors may offer options in the treatment of BRBNS patients...
  9. ncbi Association of stem cell-related markers and survival in astrocytic gliomas
    Feng Wan
    Division of Neurosurgical Research, Department of Neurosurgery, University of Heidelberg, INF 400, 69120 Heidelberg, Germany
    Biomarkers 16:136-43. 2011
    ..Our findings suggest that immature glioma cells are involved in tumour growth and tumour progression and significantly impact on patient prognosis...